GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
MIGHX
Price
$38.04
Change
-$1.65 (-4.16%)
Updated
Apr 3 closing price
Net Assets
11.64B
Ad is loading...

GFACX vs MIGHX

Header iconGFACX vs MIGHX Comparison
Open Charts GFACX vs MIGHXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
MFS Massachusetts Inv Gr Stk R3
Price$38.04
Change-$1.65 (-4.16%)
VolumeN/A
Net Assets11.64B
GFACX vs MIGHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MIGHX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MIGHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. MIGHX (11.6B). MIGHX pays higher dividends than GFACX: MIGHX (0.24) vs GFACX (0.00). GFACX was incepted earlier than MIGHX: GFACX (24 years) vs MIGHX (20 years). GFACX (1.36) is less costly to investors than MIGHX (0.71). GFACX is a more actively managed with annual turnover of: 25.00 vs. MIGHX (19.00). MIGHX has a lower initial minimum investment than GFACX: MIGHX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. MIGHX (-3.98). GFACX (59.73) and MIGHX (56.90) have equivalent 5 years return.
GFACXMIGHXGFACX / MIGHX
Total Expense Ratio1.360.71192%
Annual Report Gross Expense Ratio1.360.71192%
Fund Existence24 years20 years-
Gain YTD-5.003-4.269117%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets280B11.6B2,414%
Annual Yield % from dividends0.000.24-
Returns for 1 year-1.75-3.9844%
Returns for 3 years0.631.7237%
Returns for 5 years59.7356.90105%
Returns for 10 years44.4667.6366%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences